Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 28, 2008

View Archived Issues

EP4 receptor blocker may be useful in treating chronic arthritis

Mechanisms behind protective effects of KAI-9803 in stroke model determined

Glatiramer and steroid combination treatment beneficial in relapsing-remitting multiple sclerosis

GTx reports results from phase III clinical trial of toremifene citrate 80 mg

Recent Janssen patent discloses antiallergic and antiasthmatic agents

New local anesthetic compounds patented by PharmacoFore

Acambis initiates preclinical testing of dl5-29 HSV-2 vaccine

Bionomics initiates treatment in phase I clinical trial of BNC-105 anticancer drug

CollaGenex signs definitive merger agreement with Galderma

Verona Pharma plans clinical trials of RPL-554 for allergic respiratory diseases

Dr. Falk Pharma initiates phase II clinical study of Dong-A's udenafil for portal hypertension

ADVR signs research agreement with Northeastern University for AVR-118 in cancer

SV2A protein a target in partial and generalized epilepsy

Javelin completes subject accrual in the last of four phase I clinical studies of PMI-150

Health Canada approves Welichem Biotech's CTA for phase IIa clinical trial of WBI-1001

Actelion withdraws application to EMEA for extension of indication for Zavesca

Addex achieves preclinical milestone in agreement with Merck & Co. for allosteric modulators

ImmuPharma initiates dosing in phase IIb trial of IPP-201101 for systemic lupus erythematosus

Osiris reports interim results from phase I trial of Prochymal for myocardial infarction

Synthetic Blood awarded USD 1.9 million grant for phase IIb clinical trial of Oxycyte

Immunosyn reports results from proof-of-concept trial of SF-1019 for diabetic ulcers

VioQuest and the National Cancer Institute enter agreement for Akt inhibitor VQD-002

NPIL commences phase I P-1201-07 trials for metabolic disorders in Europe

FDA issues not approvable letter to Kyowa Hakko for istradefylline in Parkinson's

Novel antithrombotic agents described in recent Fournier and sanofi-aventis patents

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...